Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2014 | 1 |
2019 | 1 |
2020 | 1 |
2022 | 1 |
2024 | 2 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials.
Lancet. 2022 Feb 19;399(10326):729-740. doi: 10.1016/S0140-6736(22)00010-1. Epub 2022 Jan 24.
Lancet. 2022.
PMID: 35085502
Clinical Trial.
TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2.
Khanani AM, Kotecha A, Chang A, Chen SJ, Chen Y, Guymer R, Heier JS, Holz FG, Iida T, Ives JA, Lim JI, Lin H, Michels S, Quezada Ruiz C, Schmidt-Erfurth U, Silverman D, Singh R, Swaminathan B, Willis JR, Tadayoni R; TENAYA and LUCERNE Investigators.
Khanani AM, et al.
Ophthalmology. 2024 Feb 19:S0161-6420(24)00134-9. doi: 10.1016/j.ophtha.2024.02.014. Online ahead of print.
Ophthalmology. 2024.
PMID: 38382813
Free article.
Item in Clipboard
Initial treatment for polypoidal choroidal vasculopathy: Ranibizumab combined with photodynamic therapy or fixed-dosing aflibercept monotherapy.
Yoneda A, Wakiyama H, Kurihara J, Kitaoka T.
Yoneda A, et al.
Eur J Ophthalmol. 2020 Nov;30(6):1473-1479. doi: 10.1177/1120672119871886. Epub 2019 Sep 2.
Eur J Ophthalmol. 2020.
PMID: 31476891
Item in Clipboard
Factors Associated with Success of Switching to Faricimab for Neovascular Age-Related Macular Degeneration Refractory to Intravitreal Aflibercept.
Machida A, Oishi A, Ikeda J, Kurihara J, Yoneda A, Tsuiki E, Hirata Y, Murakami R, Kitaoka T.
Machida A, et al. Among authors: yoneda a.
Life (Basel). 2024 Apr 4;14(4):476. doi: 10.3390/life14040476.
Life (Basel). 2024.
PMID: 38672747
Free PMC article.
Item in Clipboard
Comparison of corneal safety and intraocular pressure-lowering effect of tafluprost ophthalmic solution with other prostaglandin ophthalmic solutions.
Kumagami T, Wakiyama H, Kusano M, Kajiyama A, Miura Y, Uematsu M, Yoneda A, Kurihara J, Suzuma K, Kitaoka T.
Kumagami T, et al. Among authors: yoneda a.
J Ocul Pharmacol Ther. 2014 May;30(4):340-5. doi: 10.1089/jop.2013.0132. Epub 2014 Feb 27.
J Ocul Pharmacol Ther. 2014.
PMID: 24576066
Free article.
Item in Clipboard
Cite
Cite